Bayesian analysis of the early cold stored platelet transfusion following severe injury randomized clinical trial
Open Access
- 23 July 2026
- journal article
- Published by BMJ in Trauma Surgery & Acute Care Open
- Vol. 11 (3) , e002145
Abstract
Background: The Early Cold Stored Platelet Transfusion Following Severe Trauma Injury Trial evaluated the safety and efficacy of cold stored platelet (CSP) transfusion in injured patients at risk of hemorrhagic shock. It was a phase II, multicenter, randomized clinical trial conducted from June 2022 to September 2023 at five US level 1 trauma centers. A total of 200 adult patients at risk of hemorrhagic shock (102 CSP, 98 standard care (SC)) were included. Median age was 34±13 years, 85% were males, and injury severity was similar between groups. The original frequentist analysis did not demonstrate a statistically significant difference in 24-hour mortality between CSP (5.9%) transfusion and SC (10.2%, p=0.28). Methods: To provide further insight into these findings, a Bayesian logistic regression outcome model with an uninformative prior was performed. To validate the findings further, a sensitivity analysis was performed in addition to analysis using a beta-binomial Bayesian model. Results: The Bayesian logistic regression model yielded an 89.1% posterior probability that CSP transfusion reduced 24-hour mortality (ß 1 =−0.668, 95% highest posterior density interval: −1.7 to 0.48). This posterior distribution indicates it is 8.1 times more likely that CSP transfusion improves 24-hour mortality than not. Sensitivity analyses across a spectrum of priors consistently produced posterior probabilities >81%. The beta-binomial model demonstrated a similar 86.2% probability that CSP transfusion reduced 24-hour mortality. Conclusion: These findings suggest a high likelihood of mortality benefit with early CSP transfusion in injured patients at risk of hemorrhagic shock and illustrate the added interpretive value of Bayesian analysis in trauma trials with low event rates. Level of evidence: Level II—therapeutic/care management.Keywords
Funding Information
- U.S. Department of War (Contract No. W81XWH-16-D-0024, Task Order W81XWH-)
This publication has 31 references indexed in Scilit:
- Cold-stored platelet hemostatic capacity is maintained for three weeks of storage and associated with taurine metabolismJournal of Thrombosis and Haemostasis, 2023
- Epidemiology of Trauma-Related Hemorrhage and Time to Definitive Care Across North America: Making the Case for Bleeding Control EducationPrehospital and Disaster Medicine, 2023
- Association of Whole Blood With Survival Among Patients Presenting With Severe Hemorrhage in US and Canadian Adult Civilian Trauma CentersJAMA Surgery, 2023
- A Tutorial on Modern Bayesian Methods in Clinical TrialsTherapeutic Innovation & Regulatory Science, 2023
- Bayesian Analysis Reporting GuidelinesNature Human Behaviour, 2021
- Principles and Reporting of Bayesian TrialsJournal of Thoracic Oncology, 2021
- Therapeutic Utility of Cold-Stored Platelets or Cold-Stored Whole Blood for the Bleeding Hematology-Oncology PatientHematology/Oncology Clinics of North America, 2019
- Cold-stored platelets: A product with function optimized for hemorrhage controlTransfusion and Apheresis Science, 2019
- Transfusion of Plasma, Platelets, and Red Blood Cells in a 1:1:1 vs a 1:1:2 Ratio and Mortality in Patients With Severe TraumaJAMA, 2015
- Bayesian statistics in oncologyCancer, 2009